Posted by Michael Wonder on 22 Feb 2017
Lawsuit accuses drug makers of conspiring to hike insulin prices
22 February 2017 - More than 29 million Americans live with diabetes, and for some six million of them, insulin is a life or death medication.
Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit accuses the three insulin manufacturers of conspiring to raise their prices. The drug makers deny the allegations.
Those high prices, combined with rising insurance deductibles, mean many people who rely on insulin are feeling sticker shock. Even doctors say without a way to pay, some patients are left facing impossible choices, reports CBS News correspondent Anna Werner.
